Protalix BioTherapeutics
PLX
PLX
62 hedge funds and large institutions have $11.9M invested in Protalix BioTherapeutics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 11 closing their positions.
Holders
62
Holders Change
-3
Holders Change %
-4.62%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
21
Closed
11
Calls
$62K
Puts
$17K
Net Calls
+$45K
Net Calls Change
-$789K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$1.04M |
2 |
VF
2
Virtu Financial
New York
|
$198K |
3 |
TSS
3
Two Sigma Securities
New York
|
$107K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$47.6K |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$950K |